Genetically engineered mesenchymal stem cell therapy using self-assembling supramolecular hydrogels
- 1 December 2015
- journal article
- review article
- Published by Elsevier in Journal of Controlled Release
- Vol. 220, 119-129
Abstract
No abstract availableKeywords
Funding Information
- Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (HI14C1658)
- Bio & Medical Technology Development Program (2012M3A9C6049791))
- Korean government (IBS-R007-D1)
- Institute for Basic Science
This publication has 146 references indexed in Scilit:
- Mesenchymal stem cells engineered for cancer therapyAdvanced Drug Delivery Reviews, 2012
- X-Ray-Visible Microcapsules Containing Mesenchymal Stem Cells Improve Hind Limb Perfusion in a Rabbit Model of Peripheral Arterial DiseaseStem Cells, 2012
- Mesenchymal stem cell therapy: Two steps forward, one step backTrends in Molecular Medicine, 2010
- Designing materials to direct stem-cell fateNature, 2009
- Naturally derived myocardial matrix as an injectable scaffold for cardiac tissue engineeringBiomaterials, 2009
- Marrow stromal cell transplantation in stroke and traumatic brain injuryNeuroscience Letters, 2009
- Viral vectors: from virology to transgene expressionBritish Journal of Pharmacology, 2009
- Hypoxia-Induced Lysyl Oxidase Is a Critical Mediator of Bone Marrow Cell Recruitment to Form the Premetastatic NicheCancer Cell, 2009
- Injectable biodegradable hydrogel composites for rabbit marrow mesenchymal stem cell and growth factor delivery for cartilage tissue engineeringBiomaterials, 2007
- Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cellsNature Biotechnology, 2002